Cannabis-based medicinal products are associated with a significant reduction in depression severity over the course of a six month examination period. This is according to the findings of a study being published in the newest issue of the journal Expert Review of Neurotherapeutics. The study was conducted by researchers at Kings College London, Imperial College … Continue reading Cannabis Products Associated With Reductions in Depression Severity at 1, 3, and 6 Months